Ensayos clínicos de Lupus en Tennessee
13 estudios sobre Lupus buscan participantes en Tennessee.
Ciudades en Tennessee
Texto oficial del estudio (inglés)
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Memphis
- Research Site, Memphis
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07430306A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- West Tennessee Research Institute - Jackson /ID# 284561, Jackson
ReclutandoFase 1
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07607964A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- West Tennessee Research Institute, Jackson
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07438496A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
ReclutandoFase 2
Edades de 18 a 74 · Todos los sexos · Actualizado el 17 sept 2026 · NCT07409181A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50001, Jackson
- Sl0044 50693, Murfreesboro
ReclutandoFase 3
Edades de 16 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06617325A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Murfreesboro Medical Clinic, Murfreesboro
ReclutandoEstudio observacional
Edades de 16 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT07175285A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- Private Practice - Dr. Ramesh C. Gupta /ID# 275826, Memphis
ReclutandoFase 1
Edades de 18 a 75 · Todos los sexos · Actualizado el 10 ago 2026 · NCT06977724A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Memphis
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07260877Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
ReclutandoFase 3
Edades de 12 a 100 · Todos los sexos · Actualizado el 8 jul 2026 · NCT06133972A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Regional One Health, Memphis
ReclutandoFase 1
Edades de 18 a 70 · Todos los sexos · Actualizado el 5 jun 2026 · NCT066133602-HOBA in Systemic Lupus Erythematosus
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 22 may 2026 · NCT07225543A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Regional One Health, Memphis
ReclutandoFase 1
Edades de 12 a 70 · Todos los sexos · Actualizado el 22 may 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Vanderbilt University Medical Center, Nashville
ReclutandoEstudio observacional
Edades de 18 a 110 · Todos los sexos · Actualizado el 15 abr 2026 · NCT05934149De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.